Skip to main content
SpringerLink
Log in
Book cover

Therapie innerer Krankheiten pp 119–143Cite as

Chronische Herzinsuffizienz

  • Chapter

  • 10 Accesses

Zusammenfassung

Unter einer Herzinsuffizienz versteht man eine eingeschränkte körperliche Belastbarkeit aufgrund einer nachweisbaren kardialen Funktionsstörung (WHO-Definition). Bei Patienten mit Herzinsuffizienz besteht ein Mißverhältnis zwischen der geförderten Blutmenge und dem der jeweiligen Situation entsprechenden Blutbedarf. Bei einem Krankheitsverlauf über Wochen und Monate handelt es sich um eine chronische Herzinsuffizienz, im Gegensatz zur akuten Herzinsuffizienz, bei der die kardialen Funktionsstörungen mit entsprechender Symptomatik im Verlauf von Minuten bis Stunden auftreten. Die chronische Herzinsuffizienz ist die häufigste kardiale Erkrankung. Wegen der schlechten Prognose im Stadium der manifesten Herzinsuffizienz NYHA III und IV (Letalität 20–40 %/Jahr) ist eine früühzeitige Diagnostik und Therapie notwendig (Übersicht 1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anand IS, Kalra GS, Ferrari R, Wahi PL, Harris PC, Poole Wilson PA (1990) Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int j Cardial 28: 341–346

    Article  CAS  Google Scholar 

  2. Böhm M, Beuckelmann DJ, Schwinger RHG, Erdmann E (1993) Aktuelle pathophysiologische Aspekte der Herzinsuffizienz. Internist 34:886–901

    PubMed  Google Scholar 

  3. Burkart F, Erdmann E, Hanrath P, Kübler W, Mutschler E, Riegger G, Riecker G, Scholz H, Schultheiß H.-P. (1993) Consensuskonferenz „Therapie der chronischen Herzinsuffizienz“. Z Kardiol 82:200–206

    PubMed  CAS  Google Scholar 

  4. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman B, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C (1991) A Comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303–310

    Article  PubMed  CAS  Google Scholar 

  5. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450–456

    Article  PubMed  CAS  Google Scholar 

  6. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R for the Milrinone Multicenter Trial Group (1989) A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320: 677–683

    Article  PubMed  CAS  Google Scholar 

  7. Dzau VJ, Hollenberg NK (1984) Renal response to captopril in severe heart failure: Role of furosemide in natriuresis and reversal of hyponatremia. Ann Int Med100:777–782

    Article  PubMed  CAS  Google Scholar 

  8. Engelmeier RS, O’Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM(1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double — blind, randomized, placebocontrolled trial. Circulation 72:536–546.

    Article  PubMed  CAS  Google Scholar 

  9. Erdmann E, Beuckelmann D, Böhm M, Schwinger RHG(1992) Klinische Gesichtspunkte der medikamentösen Differentialtherapie der chronischen Herzinsuffizienz. Z Kardiol 81 [Supp 14]: 97–103

    PubMed  Google Scholar 

  10. Ferguson DW, Berg WI, Sanders JS, Roach PJ, Kempf JS, Kienzle MG(1989) Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 80: 65–77

    Article  PubMed  CAS  Google Scholar 

  11. Gheorghiade M, Clair CS, Clair JS, Beller GA (1987) Hemodynamic Effects of Intravenous Digoxin in Patients With Severe Heart Failure Initially Treated With Diuretics and Vasodilators. J Am Coll Cardiol 9:849–857

    Article  PubMed  CAS  Google Scholar 

  12. Gheorghiade M, Hall V, Lakier JB, Goldstein S (1989) Comparative hemodynamic and neurohormonal effects to intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll cardiol 13:134–142

    Article  PubMed  CAS  Google Scholar 

  13. Jahrmärker H (1993) Wann muß, wann soll, wann kann ich ACE-Hemmer bei Herzinsuffizienz geben? Med Klin 88: 496–502

    Google Scholar 

  14. Kao W, Gheorghiade M, Hall V, Goldstein S (1989) Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idopathic dilated cardiomyopathy. Am J Cardiol 64: 609–613

    Article  PubMed  CAS  Google Scholar 

  15. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D., Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S, Pouleur Hfor the SOLVD Investigators (1992) Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86: 431–438

    Article  PubMed  CAS  Google Scholar 

  16. Lambertz H, Meyer J, Erbel R (1984) Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 69: 298–305

    Article  PubMed  CAS  Google Scholar 

  17. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group (1993) The effect of antiothensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456–1462

    Article  PubMed  CAS  Google Scholar 

  18. Mathur PN, Powles ACP, Pugsley SO, McEwan MP, Campbell EJM (1981) Effect of digoxin on right ventricular function in severe chronic airflow obstruction. Ann Int Med 95: 283–288

    Article  PubMed  CAS  Google Scholar 

  19. Nicklas JM, McKenna WJ, Stewart RA, Mickelson JK, Das SK, Schork MA, Krikler SJ, Quain LA, Morady F, Pitt B (1991) Prospective, double-blind, placebo-controlled trail of lowdose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular extopy. Am Heart J 122:1016–1021

    Article  PubMed  CAS  Google Scholar 

  20. Packer M et al., for the RADIANCE-Study (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Englj med 329:1–7

    Article  CAS  Google Scholar 

  21. Packer M, Leier CV(1987) Survival in cogestive heart failure during treatment with drugs with positive inotropic actions. Circulation 75 [Suppl IV]: IV -55

    Google Scholar 

  22. Paul M, Bachmann J, Ganten D (1992) The tissue reninangiotensin systems in cardiovascular disease. Trends Cardiovasc Med 2:94–99

    Article  PubMed  CAS  Google Scholar 

  23. Richardson A, Bayliss J, Scriven AJ, Parameshwar J, PooleWilson PA, Sutton GC (1987) Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 26: 709–711

    Article  Google Scholar 

  24. Scheid W von, Ziegler U, Kemkes BM, Erdmann E(1991) Heart transplantation: Hemodynamics over a five-year period. J Heart Lung Transplant 10:342–350

    Google Scholar 

  25. Schobel HP, Oren RM, Roach PJ, Mark AL, Ferguson DW (1991) Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans. Circulation 84:1118–1129

    Article  PubMed  CAS  Google Scholar 

  26. Schwinger RHG, Böhm M, Erdmann E (1990) Effectiveness of cardiac glycosides in human myocardium with and without „downregulated“ beta-adrenoceptors. J Cardiovasc Pharmacol 15: 692–697

    Article  PubMed  CAS  Google Scholar 

  27. Schwinger RHG, Böhm M, Müüller-Ehmsen J, Uhlmann R, Schmidt U, Stäblein A, Überfuhr P, Kreuzer E, Reichart B, Eissner H-J, Erdmann E (1993) Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88:2267–2276

    Article  PubMed  CAS  Google Scholar 

  28. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828

    Google Scholar 

  29. The CONSENSUS Trial Study Group (1987) Effexts on enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 429–435

    Google Scholar 

  30. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302

    Article  Google Scholar 

  31. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691

    Article  Google Scholar 

  32. The Xamoterol in Severe Heart Failure Study Group (1990) Xamaterol in serve heart failure. Lancet 336:1–6

    Article  Google Scholar 

  33. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and betadrenergic receptors in the failing human heart. Circulation 87: 454–463

    Article  PubMed  CAS  Google Scholar 

  34. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK on Behalf of the PROVED Investigative Group (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. J Am Coll Cardiol 22: 955–962

    Article  PubMed  CAS  Google Scholar 

  35. Waagstein F, Bristow MR, Schwedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342/11:1441–1446

    Article  PubMed  CAS  Google Scholar 

  36. Woodley SL, Gilbert EM, Anderson JL, O’Connell JB, Deitchman D, Yanowith FG, Mealey PC, Volkmann K, Renlund DG, Menlove R, Bristow MR (1991) Beta-blockade with bucindolol in heart failure caused by ischemic versus idopathie dilated cardiomyopathy. Circulation 84:2426–2441

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Erdmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Klinikum Großhadern, Marchioninistraße 15, D-81377, München, Deutschland

    Gustav Paumgartner

  2. Kastanienallee 14, D-82049, Großhesselohe, Deutschland

    Gerhard Riecker

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Erdmann, E. (1995). Chronische Herzinsuffizienz. In: Paumgartner, G., Riecker, G. (eds) Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10479-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10479-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10480-4

  • Online ISBN: 978-3-662-10479-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation